XML 12 R7.htm IDEA: XBRL DOCUMENT v3.3.1.900
Label Element Value
Institutional and Investor Class Prospectus | Turner Medical Sciences Long/Short Fund  
Risk/Return: rr_RiskReturnAbstract  
Risk/Return [Heading] rr_RiskReturnHeading Turner Medical Sciences Long/Short Fund
Objective [Heading] rr_ObjectiveHeading Investment Objective
Objective, Primary [Text Block] rr_ObjectivePrimaryTextBlock

The Turner Medical Sciences Long/Short Fund seeks capital appreciation.

Expense [Heading] rr_ExpenseHeading Fund Fees and Expenses
Expense Narrative [Text Block] rr_ExpenseNarrativeTextBlock

This table describes the fees and expenses that you may pay if you buy and hold Fund shares.

Operating Expenses Caption [Text] rr_OperatingExpensesCaption Annual Fund Operating Expenses (expenses that you pay each year as a percentage of the value of your investment)
Fee Waiver or Reimbursement over Assets, Date of Termination rr_FeeWaiverOrReimbursementOverAssetsDateOfTermination Jan. 31, 2017
Portfolio Turnover [Heading] rr_PortfolioTurnoverHeading Portfolio Turnover
Portfolio Turnover [Text Block] rr_PortfolioTurnoverTextBlock

The Fund pays transaction costs, such as commissions, when it buys and sells securities (or "turns over" its portfolio). A higher portfolio turnover rate may indicate higher transaction costs and may result in higher taxes when Fund shares are held in a taxable account. These costs, which are not reflected in annual fund operating expenses or in the example, affect the Fund's performance. During the most recent fiscal year, the Fund's portfolio turnover rate was 206% of the average value of its portfolio.

Portfolio Turnover, Rate rr_PortfolioTurnoverRate 206.00%
Expense Example [Heading] rr_ExpenseExampleHeading Example
Expense Example Narrative [Text Block] rr_ExpenseExampleNarrativeTextBlock

This Example is intended to help you compare the cost of investing in the Fund with the cost of investing in other mutual funds. The Example assumes that you invest $10,000 in the Fund for the time periods indicated and then redeem all of your shares at the end of those periods. The Example also assumes that your investment has a 5% return each year, that the Fund's operating expenses will remain the same and that you reinvest all dividends and distributions.

Expense Example by, Year, Caption [Text] rr_ExpenseExampleByYearCaption Although your actual costs may be higher or lower, based on these assumptions your costs would be:
Strategy [Heading] rr_StrategyHeading Principal Strategy
Strategy Narrative [Text Block] rr_StrategyNarrativeTextBlock

The Turner Medical Sciences Long/Short Fund invests primarily (at least 80% of its net assets) in stocks of companies engaged in the health care sector using a long/short growth strategy in seeking to capture alpha, reduce volatility, and preserve capital in declining markets. This is a non-fundamental investment policy that can be changed by the Fund upon 60 days prior notice to shareholders. Primarily, the Fund takes long positions in those equity securities that have been identified by the Adviser as undervalued and likely to increase in price, and short positions in those equity securities that have been identified by the Adviser as overvalued and likely to decrease in price. The Fund's holdings may generally range from small companies with over $250 million in market capitalization at the time of purchase to larger, established firms in the health care industry. The Fund may continue to hold securities of companies whose market capitalization was within such range at the time of purchase but whose current market capitalization may be outside of that range. Investments may also be made in other sectors of the equity markets.


It is anticipated that the Fund will typically hold between 15 and 75 securities long, and between 15 and 75 securities short, with a typical allocation generally resulting in a net long exposure, although there can be no assurance that will be the case.


The Fund may invest and trade, both long and short, in a broad range of domestic and foreign equities (including, common stock, preferred stock, or securities convertible into common stock). The Fund's investments in foreign stocks may include emerging market securities.


The Fund will buy and sell securities frequently as part of its investment strategy.

Risk [Heading] rr_RiskHeading Principal Risks
Risk Narrative [Text Block] rr_RiskNarrativeTextBlock

The Fund is intended for investors seeking long-term growth of capital.


Since it purchases equity securities, the Fund is subject to the risk that stock prices will fall over short or extended periods of time. You could lose all, or a substantial portion, of your investment in the Fund.


The Fund is subject to the risks associated with health care-related companies. Many health care-related companies are smaller and less seasoned than companies in other sectors. Health care-related companies may also be strongly affected by scientific or technological developments and their products may quickly become obsolete. Many health care-related companies offer products and services that are subject to governmental regulation and may be adversely affected by changes in governmental policies or laws.


The Fund is subject to the risks associated with selling securities short. A short sale results in a loss if the price of the securities sold short increases. In a generally rising market, short positions may be more likely to result in losses because securities sold short may be more likely to increase in value.


The Fund is subject to the risk that small, medium and large capitalization stocks may underperform other segments of the equity market or the equity markets as a whole. The medium and small capitalization companies the Fund invests in may be more vulnerable to adverse business or economic events than larger, more established companies. In particular, these medium and small sized companies may have limited product lines, markets and financial resources, and may depend upon a relatively small management group. Therefore, medium and small capitalization stock prices may be more volatile than those of larger companies. The Fund invests long in companies that Turner believes are favorably priced in relation to their fundamental value and will likely appreciate over time and short in securities of companies that Turner believes are overpriced in relation to their fundamental value and will likely depreciate over time.


The Fund is subject to risks due to its foreign investments. Foreign investments may be riskier than U.S. investments because of factors such as foreign government restrictions, changes in currency exchange rates, incomplete financial information about the issuers of securities, and political or economic instability. Foreign stocks may be more volatile and less liquid than U.S. stocks. The risks associated with foreign investments are heightened when investing in emerging markets. The government and economies of emerging market countries feature greater instability than those of more developed countries. Such investments tend to fluctuate in price more widely and to be less liquid than other foreign investments.


The Fund's investments will generate taxable income and realized capital gains. Shareholder redemptions may force the Fund to sell securities at an inappropriate time, also resulting in realized gains.


The Fund's ability to buy and sell securities frequently may result in higher transaction costs and additional tax liabilities.

Risk Lose Money [Text] rr_RiskLoseMoney You could lose all, or a substantial portion, of your investment in the Fund.
Bar Chart and Performance Table [Heading] rr_BarChartAndPerformanceTableHeading Performance Information
Performance Narrative [Text Block] rr_PerformanceNarrativeTextBlock

The bar chart and the performance table below provide some indication of the risks and volatility of an investment in the Fund. Of course, the Fund's past performance, before and after taxes, does not necessarily indicate how the Fund will perform in the future. Updated performance information is available on the Fund's website at www.turnerinvestments.com.

Performance Information Illustrates Variability of Returns [Text] rr_PerformanceInformationIllustratesVariabilityOfReturns The bar chart and the performance table below provide some indication of the risks and volatility of an investment in the Fund.
Performance Availability Website Address [Text] rr_PerformanceAvailabilityWebSiteAddress www.turnerinvestments.com
Performance Past Does Not Indicate Future [Text] rr_PerformancePastDoesNotIndicateFuture Of course, the Fund's past performance, before and after taxes, does not necessarily indicate how the Fund will perform in the future.
Bar Chart Narrative [Text Block] rr_BarChartNarrativeTextBlock

The performance of Institutional Class and Investor Class Shares will differ due to differences in expenses. This bar chart shows changes in the performance of the Fund's Institutional Class Shares from year to year since the Fund's inception.1


Bar Chart Footnotes [Text Block] rr_BarChartFootnotesTextBlock

1  The above information is based on a calendar year. The Fund's Institutional Class Shares commenced operations on February 7, 2011.

Bar Chart Closing [Text Block] rr_BarChartClosingTextBlock
Best Quarter  

Worst Quarter

 
24.89
(03/31/15)

%

  (6.76
(12/31/14)

)%

 
Highest Quarterly Return, Label rr_HighestQuarterlyReturnLabel Best Quarter
Highest Quarterly Return, Date rr_BarChartHighestQuarterlyReturnDate Mar. 31, 2015
Highest Quarterly Return rr_BarChartHighestQuarterlyReturn 24.89%
Lowest Quarterly Return, Label rr_LowestQuarterlyReturnLabel Worst Quarter
Lowest Quarterly Return, Date rr_BarChartLowestQuarterlyReturnDate Dec. 31, 2014
Lowest Quarterly Return rr_BarChartLowestQuarterlyReturn (6.76%)
Performance Table Uses Highest Federal Rate rr_PerformanceTableUsesHighestFederalRate After-tax returns are calculated using the highest individual federal income tax rate and do not reflect the impact of state and local taxes.
Performance Table Not Relevant to Tax Deferred rr_PerformanceTableNotRelevantToTaxDeferred Your after-tax returns may differ from those shown. The after-tax returns do not apply to shares held in an IRA, 401(k) or other tax-deferred account.
Performance Table One Class of after Tax Shown [Text] rr_PerformanceTableOneClassOfAfterTaxShown The after-tax figures shown are for Institutional Class Shares only and will vary for Investor Shares.
Performance Table Narrative rr_PerformanceTableNarrativeTextBlock

This table compares the Fund's average annual total returns for the periods ended December 31, 2015 to those of the S&P 500 Health Care Index, Barclays Capital U.S. Aggregate Bond Index and Lipper Long/Short Equity Funds Classification. After-tax returns are calculated using the highest individual federal income tax rate and do not reflect the impact of state and local taxes. The after-tax figures shown are for Institutional Class Shares only and will vary for Investor Shares. Your after-tax returns may differ from those shown. The after-tax returns do not apply to shares held in an IRA, 401(k) or other tax-deferred account.

Caption rr_AverageAnnualReturnCaption Average Annual Total Returns (for the periods ended December 31, 2015)
Institutional and Investor Class Prospectus | Turner Medical Sciences Long/Short Fund | S&P 500 Health Care Index  
Risk/Return: rr_RiskReturnAbstract  
Average Annual Returns, 1 Year rr_AverageAnnualReturnYear01 6.89% [1]
Average Annual Returns, Since Inception rr_AverageAnnualReturnSinceInception 20.15% [1]
Average Annual Returns, Inception Date rr_AverageAnnualReturnInceptionDate Feb. 07, 2011 [1]
Institutional and Investor Class Prospectus | Turner Medical Sciences Long/Short Fund | Barclays Capital U.S. Aggregate Bond Index  
Risk/Return: rr_RiskReturnAbstract  
Average Annual Returns, 1 Year rr_AverageAnnualReturnYear01 0.55% [2]
Average Annual Returns, Since Inception rr_AverageAnnualReturnSinceInception 3.49% [2]
Average Annual Returns, Inception Date rr_AverageAnnualReturnInceptionDate Feb. 07, 2011 [2]
Institutional and Investor Class Prospectus | Turner Medical Sciences Long/Short Fund | Lipper Long/Short Equity Funds Classification  
Risk/Return: rr_RiskReturnAbstract  
Average Annual Returns, 1 Year rr_AverageAnnualReturnYear01 (1.69%) [3]
Average Annual Returns, Since Inception rr_AverageAnnualReturnSinceInception 3.99% [3]
Average Annual Returns, Inception Date rr_AverageAnnualReturnInceptionDate Feb. 07, 2011 [3]
Institutional and Investor Class Prospectus | Turner Medical Sciences Long/Short Fund | Institutional Class  
Risk/Return: rr_RiskReturnAbstract  
Investment Advisory Fees rr_ManagementFeesOverAssets 1.50%
Distribution (12b-1) Fees rr_DistributionAndService12b1FeesOverAssets none
Shareholder Servicing Fee rr_Component1OtherExpensesOverAssets none
Other Expenses rr_OtherExpensesOverAssets 1.89%
Acquired Fund Fees and Expenses rr_AcquiredFundFeesAndExpensesOverAssets 0.01%
Total Annual Fund Operating Expenses rr_ExpensesOverAssets 3.40%
Fee Waivers and Expense Reimbursements rr_FeeWaiverOrReimbursementOverAssets (0.19%) [4]
Total Annual Fund Operating Expenses after Fee Waivers and Expense Reimbursements rr_NetExpensesOverAssets 3.21%
Expense Example, with Redemption, 1 Year rr_ExpenseExampleYear01 $ 324
Expense Example, with Redemption, 3 Years rr_ExpenseExampleYear03 1,027
Expense Example, with Redemption, 5 Years rr_ExpenseExampleYear05 1,753
Expense Example, with Redemption, 10 Years rr_ExpenseExampleYear10 $ 3,672
Annual Return 2012 rr_AnnualReturn2012 (3.67%)
Annual Return 2013 rr_AnnualReturn2013 21.48%
Annual Return 2014 rr_AnnualReturn2014 5.69%
Annual Return 2015 rr_AnnualReturn2015 18.32%
Average Annual Returns, 1 Year rr_AverageAnnualReturnYear01 18.32%
Average Annual Returns, Since Inception rr_AverageAnnualReturnSinceInception 8.87%
Average Annual Returns, Inception Date rr_AverageAnnualReturnInceptionDate Feb. 07, 2011
Institutional and Investor Class Prospectus | Turner Medical Sciences Long/Short Fund | Institutional Class | After Taxes on Distributions  
Risk/Return: rr_RiskReturnAbstract  
Average Annual Returns, 1 Year rr_AverageAnnualReturnYear01 17.81%
Average Annual Returns, Since Inception rr_AverageAnnualReturnSinceInception 8.04%
Institutional and Investor Class Prospectus | Turner Medical Sciences Long/Short Fund | Institutional Class | After Taxes on Distributions and Sale of Fund Shares  
Risk/Return: rr_RiskReturnAbstract  
Average Annual Returns, 1 Year rr_AverageAnnualReturnYear01 10.78%
Average Annual Returns, Since Inception rr_AverageAnnualReturnSinceInception 6.70%
Institutional and Investor Class Prospectus | Turner Medical Sciences Long/Short Fund | Investor Class  
Risk/Return: rr_RiskReturnAbstract  
Investment Advisory Fees rr_ManagementFeesOverAssets 1.50%
Distribution (12b-1) Fees rr_DistributionAndService12b1FeesOverAssets none
Shareholder Servicing Fee rr_Component1OtherExpensesOverAssets 0.25%
Other Expenses rr_OtherExpensesOverAssets 1.89%
Acquired Fund Fees and Expenses rr_AcquiredFundFeesAndExpensesOverAssets 0.01%
Total Annual Fund Operating Expenses rr_ExpensesOverAssets 3.65%
Fee Waivers and Expense Reimbursements rr_FeeWaiverOrReimbursementOverAssets (0.19%) [4]
Total Annual Fund Operating Expenses after Fee Waivers and Expense Reimbursements rr_NetExpensesOverAssets 3.46%
Expense Example, with Redemption, 1 Year rr_ExpenseExampleYear01 $ 349
Expense Example, with Redemption, 3 Years rr_ExpenseExampleYear03 1,100
Expense Example, with Redemption, 5 Years rr_ExpenseExampleYear05 1,872
Expense Example, with Redemption, 10 Years rr_ExpenseExampleYear10 $ 3,894
Average Annual Returns, 1 Year rr_AverageAnnualReturnYear01 17.96%
Average Annual Returns, Since Inception rr_AverageAnnualReturnSinceInception 8.62%
Average Annual Returns, Inception Date rr_AverageAnnualReturnInceptionDate Feb. 07, 2011
[1] The S&P 500 Health Care Index is an unmanaged index which includes the stocks in the health-care sector of the S&P 500 Index.
[2] The Barclays Capital U.S. Aggregate Bond Index represents an unmanaged diversified portfolio of fixed income securities, including U.S. Treasuries, investment-grade corporate bonds, and mortgage-backed and asset-backed securities.
[3] The Lipper Long/Short Equity Funds Classification represents the average annualized total return for all reporting funds in the Lipper Long/Short Equity Fund category.
[4] Turner Investments, L.P. ("Turner" or the "Adviser") has contractually agreed to waive fees and reimburse Fund expenses to keep the "Total Annual Fund Operating Expenses after Fee Waivers and Expense Reimbursements" of Institutional Class Shares and Investor Class Shares (excluding interest and borrowing cost on short and long sales and short sale dividend expenses) from exceeding 1.90% and 2.15%, respectively, through January 31, 2017. Only the Board of Trustees of the Turner Funds may terminate the waiver prior to January 31, 2017. Turner may discontinue this arrangement at any time after January 31, 2017.